The hereditary spastic paraplegias - Classification and molecular genetics;Die hereditären spastischen spinalparalysen: Aktuelle klassifikation und molekulargenetische grundlagen

Aktuelle Neurologie

Volumn 28, Issue 4, 2001, Pages 153-160

  Visbeck, A ^a   Hopf, H C ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEOLIPID PROTEIN; SPASTIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 19Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 8Q; CHROMOSOME XQ; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; GENE LOCUS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; REVIEW; X CHROMOSOMAL INHERITANCE;

EID: 0035003198     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-13270     Document Type: Review

References (56)

1. Beiträge zur Pathologie des Rückenmarks
2. Familial spastic paraplegia
3. Hereditary spastic paraplegias
4. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study
5. Hereditary ataxias and spastic paraplegias: Methological aspects of a prevalence study in Portugal
6. Hereditary "pure" spastic paraplegia: A clinical and genetic study of 22 families
7. The phenotype of autosomal dominant spastic paraplegia
8. Hereditary Spastic Paraplegia: Advances in genetic research
9. A quantitative study of sensory function in hereditary spastic paraplegia
10. Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular study of 28 United Kingdom Families
11. Beobachtungen über die adulte Form der rezessiv-erblichen spastischen Spinalparalyse
12. The hereditary spastic paraplegias
13. Urodynamic evaluation of patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24
14. Strümpell's familial spastic paraplegia: Genetics and neuropathology
15. MRI of autosomal dominant pure spastic paraplegia
16. Motor and somatosensory evoked potentials in hereditary spastic paraplegia
17. Hereditary motor and sensory neuropathies and hereditary spastic paraplegia: A magnetic stimulation study
18. Central motor conduction studies in hereditary spastic paraplegia
19. Transcranial magnetic stimulation of the cortico-spinal and cortico-bulbar tracts in hereditary and sporadic spastic paraplegia
20. Multisystem involvement of the central nervous system in Strümpell's disease
21. HIV-assoziierte neurologische Erkrankungen
22. Familial Spastic Paraparesis: A case of a mitochondrial disorder
23. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria
24. Spastik: Pathophysiologie, Klinik und Pharmakotherapie. 3. Pharmakotherapie
25. Intrathekal baclofen in hereditary spastic paraparesis
26. Clinical heterogenity of autosomal recessive spastic paraplegias. Analysis of 106 patients in 46 families
27. Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p
28. Linkage of a locus for autosomal dominant familial spastic paraplegia to chromosome 2p markers
29. Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q
30. Autosomal dominant familial spastic paraplegia: Tight linkage to chromosome 15q
31. Phenotype analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q
32. A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic hereogeneity
33. A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13
34. A new locus for autosomal dominant pure hereditary spastic paraplegia, on chromosome 2q24-q34
35. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
36. Autosomal dominant spastic paraplegia with anticipation maps to a 4-cm interval on chromosome 2p21-p24 in a large German family
37. Autosomal dominant pure hereditary spastic paraplegia: A clinical, paraclinical, and genetic study
38. Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2
39. Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2
40. Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p
41. Genetic mapping to 10q23.3q24.2, in al large Italien pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy
42. Analysis of GLRA1 in hereditary and sporadic hyperplexia: A novel mutation in a family cosegregating for hyperplexia and spastic paraparesis
43. A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28
44. Linkage of "pure" autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity
45. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15
46. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3
47. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease
48. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene
49. Location score and haplotype analysis for the locus for autosomal dominant spastic ataxia of Charlevoix-Saguenay, in Chromosome region 13q
50. X-linked spastic paraplegia, (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene
51. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus
52. Refinded genetic mapping and proteolipid mutation analysis in X-linked pure hereditary spastic paraplegia
53. Quality assessment of whole genome mapping data in the refined familial spastic paraplegia interval on chromosome 14q
54. Another pedigree with pure autosomal dominant spastic paraplegia (AD-FSP) from Tibet maps to 14q11.2-q24.3
55. Autosomal dominant familial spastic paraplegia: Reduction of the FSP1 candidate region on chromosome 14q to 7cM and locus heterogeneity
56. Autosomal dominant spastic paraplegia. Refined SPG8 locus and additional genetic heterogeneity